TRAF6 and hepatocellular carcinoma: Our findings also showed that miR‐605‐3p inhibited HCC metastasis by inhibiting NF‐κB activation and that this effect of miR‐605‐3p was dependent on TRAF6, which indicates that the miR‐605‐3p/TRAF6/NF‐κB axis functions in the regulation of HCC metastasis.